S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Is this AI's biggest breakthrough to date? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Is this AI's biggest breakthrough to date? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Is this AI's biggest breakthrough to date? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Is this AI's biggest breakthrough to date? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Is this AI's biggest breakthrough to date? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Is this AI's biggest breakthrough to date? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Is this AI's biggest breakthrough to date? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Is this AI's biggest breakthrough to date? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

EUDA Health (EUDA) Competitors

$1.44
-0.01 (-0.69%)
(As of 02/22/2024 ET)

EUDA vs. NOVV, PPHP, ATPC, HHGC, HOLO, WGS, POCI, XGN, PMN, and CDIO

Should you be buying EUDA Health stock or one of its competitors? The main competitors of EUDA Health include Nova Vision Acquisition (NOVV), PHP Ventures Acquisition (PPHP), Agape ATP (ATPC), HHG Capital (HHGC), MicroCloud Hologram (HOLO), GeneDx (WGS), Precision Optics (POCI), Exagen (XGN), ProMIS Neurosciences (PMN), and Cardio Diagnostics (CDIO).

EUDA Health vs.

EUDA Health (NASDAQ:EUDA) and Nova Vision Acquisition (NASDAQ:NOVV) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Nova Vision Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

35.0% of EUDA Health shares are owned by institutional investors. Comparatively, 38.4% of Nova Vision Acquisition shares are owned by institutional investors. 43.3% of Nova Vision Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, EUDA Health's average media sentiment score of 0.00 equaled Nova Vision Acquisition'saverage media sentiment score.

Company Overall Sentiment
EUDA Health Neutral
Nova Vision Acquisition Neutral

Nova Vision Acquisition has lower revenue, but higher earnings than EUDA Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EUDA Health$9.84M3.59-$24.88MN/AN/A
Nova Vision AcquisitionN/AN/A-$80KN/AN/A

EUDA Health's return on equity of 0.00% beat Nova Vision Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
EUDA HealthN/A N/A N/A
Nova Vision Acquisition N/A -11.22%1.15%

EUDA Health and Nova Vision Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
EUDA HealthN/AN/A
Nova Vision AcquisitionN/AN/A

Summary

Nova Vision Acquisition beats EUDA Health on 4 of the 6 factors compared between the two stocks.


Get EUDA Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EUDA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EUDA vs. The Competition

MetricEUDA HealthHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$35.34M$837.09M$5.15B$7.53B
Dividend YieldN/A1.68%2.91%3.86%
P/E RatioN/A28.17127.7918.29
Price / Sales3.592.433,006.4081.55
Price / CashN/A9.6089.9753.30
Price / Book-8.442.514.304.60
Net Income-$24.88M-$62.14M$112.86M$207.29M
7 Day Performance-1.03%3.07%0.45%-1.02%
1 Month Performance-10.87%6.47%6.45%3.31%
1 Year Performance16.67%-7.80%8.11%3.73%

EUDA Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOVV
Nova Vision Acquisition
0 of 5 stars
$11.65
flat
N/AN/A$41.57MN/A0.002,021
PPHP
PHP Ventures Acquisition
0 of 5 stars
$11.07
flat
N/A+5.0%$28.78MN/A-27.672,021
ATPC
Agape ATP
0 of 5 stars
$0.35
-14.6%
N/AN/A$27.03M$1.43M-17.5330
HHGC
HHG Capital
0 of 5 stars
$10.95
-0.4%
N/A+4.3%$55.30MN/A0.002,021High Trading Volume
HOLO
MicroCloud Hologram
0 of 5 stars
$16.41
-75.3%
N/A-49.5%$83.38M$346.06M0.00101Gap Down
WGS
GeneDx
1.2304 of 5 stars
$5.24
+3.8%
N/A-47.8%$135.61M$234.69M0.001,100News Coverage
POCI
Precision Optics
0 of 5 stars
$5.67
-3.2%
N/A-17.6%$35.55M$19.22M-18.9084Gap Down
XGN
Exagen
4.5639 of 5 stars
$2.11
-1.4%
$5.50
+160.7%
-28.3%$35.98M$45.56M-1.13199Gap Down
PMN
ProMIS Neurosciences
2.1312 of 5 stars
$1.88
-5.5%
$8.00
+326.7%
-62.1%$35.41M$10,000.00-0.976News Coverage
CDIO
Cardio Diagnostics
0 of 5 stars
$1.72
-3.4%
N/A+53.5%$35.33M$12,705.000.007Upcoming Earnings

Related Companies and Tools

This page (NASDAQ:EUDA) was last updated on 2/23/2024 by MarketBeat.com Staff